These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8315521

  • 1. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [Abstract] [Full Text] [Related]

  • 2. The advantages of angiotensin II antagonism.
    Burnier M, Waeber B, Brunner HR.
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [Abstract] [Full Text] [Related]

  • 3. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 Jul; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 4. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA, Derkx FH, van den Meiracker AH.
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [Abstract] [Full Text] [Related]

  • 5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 6. Peptides as targets for antihypertensive drug development.
    Hedner T, Sun X, Junggren IL, Pettersson A, Edvinsson L.
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [Abstract] [Full Text] [Related]

  • 7. Localization of components of the renin-angiotensin system and site of action of inhibitors.
    Chai SY, Zhuo J, Mendelsohn FA.
    Arzneimittelforschung; 1993 Feb; 43(2A):214-21. PubMed ID: 8498967
    [Abstract] [Full Text] [Related]

  • 8. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y, Lefebvre J.
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [Abstract] [Full Text] [Related]

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 10. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M, Suzuki H, Naitoh M, Matsumoto A, Kageyama Y, Tsujimoto G, Saruta T.
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
    Ritter JM, Cockcroft JR, Sciberras DG, Goldberg MR.
    J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
    [Abstract] [Full Text] [Related]

  • 12. [Non-peptide antagonists to angiotensin II receptors. A review].
    Schambye HT, Hjorth SA, Schwartz TW.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3558-62. PubMed ID: 8236577
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors of the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    Arzneimittelforschung; 1993 Feb 01; 43(2A):274-8. PubMed ID: 8498978
    [Abstract] [Full Text] [Related]

  • 14. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
    Abdelrahman AM, Burrell LM, Johnston CI.
    J Hypertens Suppl; 1993 Apr 01; 11(3):S23-6. PubMed ID: 8315514
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ, Brunner HR.
    J Hum Hypertens; 1993 Aug 01; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996 Aug 01; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 17. The future role of losartan.
    Hansson L.
    J Hum Hypertens; 1995 Nov 01; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [Abstract] [Full Text] [Related]

  • 18. Various approaches to blockade of the renin-angiotensin system: persistent renin response.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1990 Dec 01; 8(7):S149-53. PubMed ID: 2095383
    [Abstract] [Full Text] [Related]

  • 19. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK, Sodhi RK, Singh M.
    Life Sci; 2007 Aug 02; 81(8):615-39. PubMed ID: 17692338
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
    Hollenberg NK.
    J Am Soc Nephrol; 1999 Jan 02; 10 Suppl 11():S239-42. PubMed ID: 9892171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.